Neurometabolic devices developer EnteroMedics has completed the acquisition of BarioSurg.

The acquisition enables EnteroMedics to access the target company’s Gastric Vest System, which is a minimally invasive, laparoscopically implanted medical device being investigated for weight loss in morbidly obese patients.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

EnteroMedics has paid $2m in cash, 1.38 million unregistered shares of its common stock, and one million unregistered shares of its conditional convertible preferred stock.

Finesse Medical has been acquired by Avery Dennison, as a part of its long-term strategic goal for industrial and healthcare materials segment.

Finesse Medical specialises in developing wound care and skin treatment products using advanced technologies, while Avery, through its business unit Vancive Medical Technologies, provides pressure-sensitive and functional materials for the retail apparel market.

"Finesse’s innovative portfolio of silicone gels and polyurethane foam dressings will complement Avery’s existing products in wound care, while it will also provide new global sales and distribution channels for Avery's products."

Finesse’s innovative portfolio of silicone gels and polyurethane foam dressings will complement Avery’s existing products in wound care, while it will also provide new global sales and distribution channels for Avery's products.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Royal Philips intends to acquire respiratory care products developer Respirtech to further expand its business unit, especially in the chronic obstructive pulmonary disease (COPD) segment.

The acquisition will strengthen Royal Philips’ respiratory care portfolio with the target company’s vest therapy solution and capabilities.

Tissue Regenix plans to purchase CellRight Technologies.

Based in Texas, US, CellRight is a biologics company specialising in the development of human osteoinductive and wound care scaffolds for use in general orthopaedic, dental and sports medicine surgical procedures.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact